SCHEMBL14732169

SCHEMBL14732169

CCc1c(Br)cccc1CP(=O)(O)O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 1/20 0.46
GABRA1 P14867 2/20 0.44
GABRB2 P47870 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
PGK1 P00558 3/20 0.39
PGK2 P07205 3/20 0.39
MMP2 P08253 2/20 0.34
MMP9 P14780 2/20 0.34
MMP12 P39900 2/20 0.34
ENPP2 Q13822 1/20 0.33
RIPK1 Q13546 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1556934 0.85 ACP3 (0.52) ACP3GABRA1GABRB2SMN1; SMN2GRIN2D
SCHEMBL8009692 0.81 GABRA1 (0.58) GABRA1GABRB2RIPK1
SCHEMBL1293279 0.79 GABRA1 (0.40) GABRA1GABRB2
Butane SCHEMBL3092282 0.79 ACP3 (0.49) ACP3GABRA1GABRB2GRIN2DGRIN3B
SCHEMBL21638770 0.78 ACP3 (0.52) ACP3GABRA1GABRB2SMN1; SMN2GRIN2D
SCHEMBL2420219 0.77 ACP3 (0.55) ACP3SMN1; SMN2GRIN2DGRIN3BGRIN1
SCHEMBL1294030 0.76 GABRA1 (0.46) GABRA1GABRB2RIPK1
SCHEMBL11499183 0.75 ACP3 (0.57) ACP3GABRA1GABRB2SMN1; SMN2GRIN2D
SCHEMBL6243179 0.74 AKR1B1 (0.46) GABRA1GABRB2GRIN2DGRIN3BGRIN1
SCHEMBL1293367 0.74 GABRA1 (0.48) GABRA1GABRB2RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563785-A1 COMPOUNDS AS AGONISTS OF S1P1 RECEPTORS Glaxo Group Limited (GB) 2013-03-06 EP disclosed
US-8389508-B2 Heterocyclic compounds GLAXO GROUP LIMITED (GB) 2013-03-05 US disclosed